speb/financial-data huggingface dataset:
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4398500000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4398500000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 860520000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 860520000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -48650000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -88670000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 162800000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Change In Payable: 621430000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 486090000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -51570000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 239390000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 239390000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 17405610000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 17405610000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 46320000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 137980000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 137980000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 46406610000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 11086370000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 18435160000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 18435160000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 1117880000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1117880000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Current Debt: 0.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 0.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1117880000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1117880000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 5765940000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5765940000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 360970000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 360970000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Depreciation: 2463460000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 2498430000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 2498430000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 642090000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 2463460000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 642090000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 120022928.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 119383721.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 12.52
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.30
MEDPLUS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1503220000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 513350000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — EBIT: 2858750000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — EBIT: 879570000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — EBITDA: 5357180000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1521660000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 860520000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -2279780000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 13040880000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 13040880000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 4809790000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -58200000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 291570000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Goodwill: 414510000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 414510000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 508950000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 508950000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 84250000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 84250000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 20053090000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 20053090000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Gross Profit: 14468030000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 4009720000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Interest Expense: 1025860000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 268410000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1025860000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 268410000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Interest Income: 259910000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 259910000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1025860000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 140370000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Inventory: 13450990000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 13450990000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 17405610000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 17405610000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3176080000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 23570000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 23570000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 46320000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 151070000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 151070000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 10080140000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 10080140000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10080140000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10080140000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 351300000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 351300000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3894670000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3894670000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Minority Interest: -6620000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: -6620000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Minority Interests: 890000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 150000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 46320000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Income: 1503220000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income: 513350000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1503220000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 513350000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1502330000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 513200000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1503220000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 513350000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1503220000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 513350000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1832890000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1502330000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 513200000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -765950000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -268410000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -2732430000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -765950000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -268410000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 12623850000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 12623850000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -584020000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 16896660000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 16896660000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 998280000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 998280000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 351300000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 351300000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1010760000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1010760000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 5290770000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1521660000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Normalized Income: 1448786981.49
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 513350000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 5404290000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Operating Income: 2385170000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 721650000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 60874640000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 15096090000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 119638946.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 119638946.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 364750000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 364750000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 197920000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 197920000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 263020000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 263020000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 94440000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 94440000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 762740000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -110000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -110000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 146990000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 157920000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1298500000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 704270000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 836040000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 836040000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 12485760000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 12485760000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 115760000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 115760000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 3537980000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3537980000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Other Special Charges: -70520000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Payables: 3828610000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 3828610000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 243490000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 390350000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 390350000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Pretax Income: 1832890000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 611160000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 18300000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -6328650000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -594500000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 402870000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 402870000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 46406610000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 11086370000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 2498430000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 642090000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 1370000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 1370000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 4297590000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4297590000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 3596220000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 10480000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1033630000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1325200000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 119693831.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 119693831.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Special Income Charges: 66410000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 68690000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 17405610000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 17405610000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 16896660000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 16896660000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 11976981.49
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Tax Provision: 330560000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 97960000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.18
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.16
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 430000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 430000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -452250000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 33600950000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 33600950000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 17405610000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 17405610000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 11198020000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 11198020000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 17398990000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 17398990000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Total Expenses: 58489470000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 14374440000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 16201960000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 16201960000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 15165790000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15165790000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10436020000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10436020000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 2980000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 2980000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 66410000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 66410000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 54885.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 54885.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Work In Process: 7240000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 7240000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 12669220000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 12669220000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Write Off: 4110000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 3377860000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 15426340000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 119655367.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 3.54
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 11397360000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 656180000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 656180000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 119994334.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.53
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 423580000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — EBIT: 801310000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 1457490000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 4028980000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 273650000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 273650000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 150000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Income: 423580000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 423580000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 423430000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 423580000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 423580000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 423430000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -273650000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -273650000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1457490000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 423580000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 651120000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 15426340000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 150190000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 717270000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 527660000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 11397360000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 656180000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 104230000.00
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.20
MEDPLUS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 14775220000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 3865670000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 18061180000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 119931535.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 4.82
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 13336760000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 727410000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 727410000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 120180873.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 4.81
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 578070000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — EBIT: 1041160000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1768570000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 4724420000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 308290000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 308290000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 190000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income: 578070000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 578070000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 577880000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 578070000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 578070000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 577880000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -308290000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -308290000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1768570000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 578070000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 858750000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 18061180000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 182410000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 811780000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 732870000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 13336760000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 727410000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 154990000.00
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
MEDPLUS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 17202430000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 14250590000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 4002140000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 68353310000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 18643850000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 3069500000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3069500000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 230380000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 230380000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -9493910000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -9493910000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 12553710000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 12553710000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -3920000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -3920000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Amortization: 36960000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 36960000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 16980000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 16980000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 119827080.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 120043152.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Basic EPS: 18.33
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.33
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 860520000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 20149810000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 20149810000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1230300000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 14243830000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 14243830000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 240110000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 240110000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1984120000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1984120000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5924610000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5924610000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 1984120000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1984120000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -365950000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -612320000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 129690000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 69780000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -992910000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 1123600000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 240110000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 240110000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 19753590000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 19753590000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 99300000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 331920000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 331920000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 50846070000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 13709440000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 20686500000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 20686500000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 1912590000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1912590000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1912590000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1912590000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 6892910000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6892910000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 492600000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 492600000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Depreciation: 2791720000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 2828680000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 2828680000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 759470000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 2791720000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 759470000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 120098369.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 120043152.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 18.29
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 5.33
MEDPLUS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 2196490000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 639830000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — EBIT: 3958230000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — EBIT: 1138220000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — EBITDA: 6786910000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1897690000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1984120000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -2555050000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 13387910000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 13387910000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 3725510000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -480000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -27100000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 321020000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Goodwill: 414510000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 414510000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 493300000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 493300000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 234300000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 234300000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 25277920000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 25277920000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Gross Profit: 17507240000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 4934410000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Interest Expense: 1204930000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 334800000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1204930000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 334800000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Interest Income: 433680000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 433680000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1204930000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 314610000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Inventory: 13816940000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 13816940000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 19753590000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 19753590000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1277160000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 16980000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 16980000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 99300000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 151070000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 151070000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 12331240000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 12331240000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12331240000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12331240000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 336070000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 336070000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 4645120000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 4645120000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Minority Interest: -7050000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: -7050000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Minority Interests: 430000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 100000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 99300000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Income: 2196490000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income: 639830000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 2196490000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 639830000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 2196060000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 639730000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2196490000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 639830000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2196490000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 639830000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2753300000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 2196060000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 639730000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -771250000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -334800000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -365680000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -771250000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -334800000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -10000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 15784010000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 15784010000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1226090000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 19260290000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 19260290000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 1212480000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1212480000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 336070000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 336070000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 1131610000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 1131610000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 6748080000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1897690000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Normalized Income: 2165518798.24
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 639830000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 4955810000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Operating Income: 3256650000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 932270000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 68353310000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 18643850000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 120003381.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 120003381.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 10000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 470070000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 470070000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 177700000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 177700000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 80290000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 80290000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 78790000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 78790000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 740570000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -110000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -110000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 229710000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 205950000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1426450000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 861500000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Payable: 801400000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 801400000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 15451980000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 15451980000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 221300000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 221300000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 3940490000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3940490000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Other Special Charges: -41980000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Payables: 3899200000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3899200000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 357420000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 493270000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 493270000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Pretax Income: 2753300000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 803420000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 3610000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -8238470000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1230300000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 422900000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 422900000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 50846070000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 13709440000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 2828680000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 759470000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 670000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 670000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 6515790000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 6515790000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 7872790000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 4210000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 1207760000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 1528780000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 120054642.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 120054642.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Special Income Charges: 38830000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 30470000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 19753590000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 19753590000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 19260290000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 19260290000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 7858798.24
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Tax Provision: 557240000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 163690000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.20
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 420000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 420000.00
MEDPLUS.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -740900000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Total Assets: 39325260000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 39325260000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 19753590000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 19753590000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Total Debt: 14243830000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 14243830000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 19746540000.00
MEDPLUS.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 19746540000.00
MEDPLUS.NS income_statement (annual, 2026-03-31) — Total Expenses: 65096660000.00
MEDPLUS.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 17711580000.00
MEDPLUS.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 19578720000.00